Literature DB >> 33488593

A Novel Biallelic STING1 Gene Variant Causing SAVI in Two Siblings.

Malak Ali Alghamdi1, Jaazeel Mulla2, Narjes Saheb Sharif-Askari3, Francisco J Guzmán-Vega4, Stefan T Arold4, Mervat Abd-Alwahed5, Nasser Alharbi6, Tarek Kashour7, Rabih Halwani8.   

Abstract

STING-associated vasculopathy of infantile-onset (SAVI) is one of the newly identified types of interferonopathies. SAVI is caused by heterozygous gain-of-function mutations in the STING1. We herein report for the first time a homozygous variant in the STING1 gene in two siblings that resulted in constitutive activation of STING gene and the SAVI phenotype. Exome sequencing revealed a novel homozygous NM_198282.3: c.841C>T; p.(Arg281Trp) variant in exon 7 of the STING1 gene. The variant segregated in the family to be homozygous in all affected and either heterozygous or wild type in all healthy. Computational structural analysis of the mutants revealed changes in the STING protein structure/function. Elevated serum beta-interferon levels were observed in the patients compared to the control family members. Treatment with Janus kinase inhibitor (JAK-I) Ruxolitinib suppressed the inflammatory process, decreased beta-interferon levels, and stopped the progression of the disease.
Copyright © 2021 Alghamdi, Mulla, Saheb Sharif-Askari, Guzmán-Vega, Arold, Abd-Alwahed, Alharbi, Kashour and Halwani.

Entities:  

Keywords:  JAK inhibitor; SAVI; STING-associated vasculopathy of infancy; STING1; cutaneous vasculopathy; interferonopathies; pulmonary inflammation

Mesh:

Substances:

Year:  2021        PMID: 33488593      PMCID: PMC7820697          DOI: 10.3389/fimmu.2020.599564

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  24 in total

1.  Stimulator of interferon genes-associated vasculitis of infancy.

Authors:  Ebun Omoyinmi; Sonia Melo Gomes; Sira Nanthapisal; Patricia Woo; Ariane Standing; Despina Eleftheriou; Nigel Klein; Paul A Brogan
Journal:  Arthritis Rheumatol       Date:  2015-03       Impact factor: 10.995

Review 2.  Dermatologic Manifestations of Monogenic Autoinflammatory Diseases.

Authors:  Kyawt Win Shwin; Chyi-Chia Richard Lee; Raphaela Goldbach-Mansky
Journal:  Dermatol Clin       Date:  2017-01       Impact factor: 3.478

3.  Activated STING in a vascular and pulmonary syndrome.

Authors:  Y Liu; A A Jesus; B Marrero; Z Deng; M Boehm; A S Paller; D Yang; S E Ramsey; G A Montealegre Sanchez; K Tenbrock; H Wittkowski; O Y Jones; H S Kuehn; C-C R Lee; M A DiMattia; E W Cowen; B Gonzalez; I Palmer; J J DiGiovanna; A Biancotto; H Kim; W L Tsai; A M Trier; Y Huang; D L Stone; S Hill; H J Kim; C St Hilaire; S Gurprasad; N Plass; D Chapelle; I Horkayne-Szakaly; D Foell; A Barysenka; F Candotti; S M Holland; J D Hughes; H Mehmet; A C Issekutz; M Raffeld; J McElwee; J R Fontana; C P Minniti; S Moir; D L Kastner; M Gadina; A C Steven; P T Wingfield; S R Brooks; S D Rosenzweig; T A Fleisher; R Goldbach-Mansky
Journal:  N Engl J Med       Date:  2014-07-16       Impact factor: 91.245

4.  [Stimulator of interferon genes-associated vasculopathy with onset in infancy: first case report in China].

Authors:  Z X Yu; L Q Zhong; H M Song; C Y Wang; W Wang; J Li; M S Ma
Journal:  Zhonghua Er Ke Za Zhi       Date:  2018-03-02

5.  Familial chilblain lupus due to a gain-of-function mutation in STING.

Authors:  Nadja König; Christoph Fiehn; Christine Wolf; Max Schuster; Emanuel Cura Costa; Victoria Tüngler; Hugo Ariel Alvarez; Osvaldo Chara; Kerstin Engel; Raphaela Goldbach-Mansky; Claudia Günther; Min Ae Lee-Kirsch
Journal:  Ann Rheum Dis       Date:  2016-08-26       Impact factor: 19.103

6.  Baricitinib experience on STING-associated vasculopathy with onset in infancy: A representative case from Turkey.

Authors:  Sibel Balci; Rabia Miray Kisla Ekinci; Adriana Almeida de Jesus; Raphaela Goldbach-Mansky; Mustafa Yilmaz
Journal:  Clin Immunol       Date:  2019-10-15       Impact factor: 3.969

7.  Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations.

Authors:  Nadia Jeremiah; Bénédicte Neven; Matteo Gentili; Isabelle Callebaut; Sophia Maschalidi; Marie-Claude Stolzenberg; Nicolas Goudin; Marie-Louis Frémond; Patrick Nitschke; Thierry J Molina; Stéphane Blanche; Capucine Picard; Gillian I Rice; Yanick J Crow; Nicolas Manel; Alain Fischer; Brigitte Bader-Meunier; Frédéric Rieux-Laucat
Journal:  J Clin Invest       Date:  2014-11-17       Impact factor: 14.808

8.  Structure of STING bound to cyclic di-GMP reveals the mechanism of cyclic dinucleotide recognition by the immune system.

Authors:  Chang Shu; Guanghui Yi; Tylan Watts; C Cheng Kao; Pingwei Li
Journal:  Nat Struct Mol Biol       Date:  2012-06-24       Impact factor: 15.369

9.  Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome.

Authors:  Stefano Volpi; Antonella Insalaco; Roberta Caorsi; Elettra Santori; Virginia Messia; Oliviero Sacco; Suzanne Terheggen-Lagro; Fabio Cardinale; Alessia Scarselli; Claudia Pastorino; Gianmarco Moneta; Giuliana Cangemi; Chiara Passarelli; Margherita Ricci; Donata Girosi; Maria Derchi; Paola Bocca; Andrea Diociaiuti; May El Hachem; Caterina Cancrini; Paolo Tomà; Claudio Granata; Angelo Ravelli; Fabio Candotti; Paolo Picco; Fabrizio DeBenedetti; Marco Gattorno
Journal:  J Clin Immunol       Date:  2019-05-29       Impact factor: 8.317

10.  Clinical application of whole-exome sequencing across clinical indications.

Authors:  Kyle Retterer; Jane Juusola; Megan T Cho; Patrik Vitazka; Francisca Millan; Federica Gibellini; Annette Vertino-Bell; Nizar Smaoui; Julie Neidich; Kristin G Monaghan; Dianalee McKnight; Renkui Bai; Sharon Suchy; Bethany Friedman; Jackie Tahiliani; Daniel Pineda-Alvarez; Gabriele Richard; Tracy Brandt; Eden Haverfield; Wendy K Chung; Sherri Bale
Journal:  Genet Med       Date:  2015-12-03       Impact factor: 8.822

View more
  3 in total

1.  Effectiveness and Safety of JAK Inhibitors in Autoinflammatory Diseases: A Systematic Review.

Authors:  Zhivana Boyadzhieva; Nikolas Ruffer; Gerd Burmester; Anne Pankow; Martin Krusche
Journal:  Front Med (Lausanne)       Date:  2022-06-27

Review 2.  Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI).

Authors:  Clémence David; Marie-Louise Frémond
Journal:  Cells       Date:  2022-01-18       Impact factor: 6.600

Review 3.  Emerging Place of JAK Inhibitors in the Treatment of Inborn Errors of Immunity.

Authors:  Jérôme Hadjadj; Marie-Louise Frémond; Bénédicte Neven
Journal:  Front Immunol       Date:  2021-09-17       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.